Back pain in Duchenne muscular dystrophy: Steroids are not always the culprit

Journal of Pediatric Orthopaedics Part B

Volumn 25, Issue 1, 2016, Pages 81-85

  Segal, Lee S ^a,b   Odgers, Ryan ^b   Carpentieri, David ^b   Shrader, M Wade ^b  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b PHOENIX CHILDREN'S HOSPITAL   (United States)

Author keywords

Duchenne muscular dystrophy; Fibrous dysplasia; Spine

Indexed keywords

ALENDRONIC ACID; DEFLAZACORT;

ADOLESCENT; ANEURYSMAL BONE CYST; ARTHRODESIS; ARTICLE; BACKACHE; CASE REPORT; COMPRESSION FRACTURE; COMPUTER ASSISTED TOMOGRAPHY; CORTICOSTEROID THERAPY; DIFFERENTIAL DIAGNOSIS; DUCHENNE MUSCULAR DYSTROPHY; FEMALE; FIBROUS DYSPLASIA; FOLLOW UP; HISTOPATHOLOGY; HUMAN; LONG TERM CARE; LUMBAR SPINE; MOBILIZATION; OSTEOBLASTOMA; PRIORITY JOURNAL; SPINE MONOSTOTIC FIBROUS DYSPLASIA; SPINE RADIOGRAPHY; VERTEBRA SPINOUS PROCESS; WALKING; BACK PAIN; COMPLICATION; FIBROUS DYSPLASIA, MONOSTOTIC; LUMBAR VERTEBRA; MALE; RADIOGRAPHY; SPINAL DISEASES;

ADOLESCENT; BACK PAIN; DIAGNOSIS, DIFFERENTIAL; FIBROUS DYSPLASIA, MONOSTOTIC; HUMANS; LUMBAR VERTEBRAE; MALE; MUSCULAR DYSTROPHY, DUCHENNE; SPINAL DISEASES;

EID: 84948665463     PISSN: 1060152X     EISSN: 14735865     Source Type: Journal    
DOI: 10.1097/BPB.0000000000000158     Document Type: Article

References (30)

1. Lebel DE, Corston JA, McAdam LC, Biggar WD, Alman BA. Glucocorticoid treatment for the prevention of scoliosis in children with Duchenne muscular dystrophy: long-term follow-up. J Bone Joint Surg Am 2013; 95:1057-1061.
2. Dooley JM, Gordon KE, MacSween JM. Impact of steroids on surgical experiences of patients with Duchenne muscular dystrophy. Pediatr Neurol 2010; 43:173-176.
3. Houde S, Filiatrault M, Fournier A, Dubé J, D'Arcy S, Bérubé D, et al. Deflazacort use in Duchenne muscular dystrophy: an 8-year follow-up. Pediatr Neurol 2008; 38:200-206.
4. King WM, Ruttencutter R, Nagaraja HN, Matkovic V, Landoll J, Hoyle C, et al. Orthopedic outcomes of long-term daily corticosteroid treatment in Duchenne muscular dystrophy. Neurology 2007; 68:1607-1613.
5. Biggar WD, Politano L, Harris VA, Passamano L, Vajsar J, Alman B, et al. Deflazacort in Duchenne muscular dystrophy: a comparison of two different protocols. Neuromuscul Disord 2004; 14:476-482.
6. Biggar WD, Harris VA, Eliasoph L, Alman B. Long-term benefits of deflazacort treatment for boys with Duchenne muscular dystrophy in their second decade. Neuromuscul Disord 2006; 16:249-255.
7. Griggs RC, Moxley RT 3rd, Mendell JR, Fenichel GM, Brooke MH, Pestronk A, Miller JP. Clinical Investigation of Duchenne Dystrophy Group. Prednisone in Duchenne dystrophy. A randomized, controlled trial defining the time course and dose response. Arch Neurol 1991; 48:383-388.
8. McAdam LC, Mayo AL, Alman BA, Biggar WD. The Canadian experience with long-term deflazacort treatment in Duchenne muscular dystrophy. Acta Myol 2012; 31:16-20.
9. Bianchi ML, Mazzanti A, Galbiati E, Saraifoger S, Dubini A, Cornelio F, Morandi L. Bone mineral density and bone metabolism in Duchenne muscular dystrophy. Osteoporos Int 2003; 14:761-767.
10. Mendell JR, Moxley RT, Griggs RC, Brooke MH, Fenichel GM, Miller JP, et al. Randomized, double-blind six-month trial of prednisone in Duchenne's muscular dystrophy. N Engl J Med 1989; 320:1592-1597.
11. Bothwell JE, Gordon KE, Dooley JM, MacSween J, Cummings EA, Salisbury S. Vertebral fractures in boys with Duchenne muscular dystrophy. Clin Pediatr (Phila) 2003; 42:353-356.
12. Vestergaard P, Glerup H, Steffensen BF, Rejnmark L, Rahbek J, Moseklide L. Fracture risk in patients with muscular dystrophy and spinal muscular atrophy. J Rehabil Med 2001; 33:150-155.
13. Sussman M. Duchenne muscular dystrophy. J Am Acad Orthop Surg 2002; 10:138-151.
14. Manzur AY, Kuntzer T, Pike M, Swan A. Glucocorticoid corticosteroids for Duchenne muscular dystrophy. Cochrane Database Syst Rev 2008; 23: CD003725.
15. Moxley RT 3rd, Pandya S, Ciafaloni E, Fox DJ, Campbell K. Change in natural history of Duchenne muscular dystrophy with long-term corticosteroid treatment: implications for management. J Child Neurol 2010; 25:1116-1129.
16. Larson CM, Henderson RC. Bone mineral density and fractures in boys with Duchenne muscular dystrophy. J Pediatr Orthop 2000; 20:71-74.
17. McDonald DG, Kinali M, Gallagher AC, Mercuri E, Muntoni F, Roper H, et al. Fracture prevalence in Duchenne muscular dystrophy. Dev Med Child Neurol 2002; 44:695-698.
18. Chapurlat RD, Delmas PD, Liens D, Meunier PJ. Long-term effects of intravenous pamidronate in fibrous dysplasia of bone. J Bone Miner Res 1997; 12:1746-1752.
19. Schoenfeld AJ, Koplin SA, Garcia R, Hornicek FJ, Mankin HJ, Raskin KA, et al. Monostotic fibrous dysplasia of the spine: a report of seven cases. J Bone Joint Surg Am 2010; 92:984-988.
20. Park SK, Lee IS, Choi JY, Cho KH, Suh KJ, Lee JW, Song JW. CTand MRI of fibrous dysplasia of the spine. Br J Radiol 2012; 85:996-1001.
21. DiCaprio MR, Enneking WF. Fibrous dysplasia. Pathophysiology, evaluation, and treatment. J Bone Joint Surg Am 2005; 87:1848-1864.
22. Mancini F, Corsi A, De Maio F, Riminucci M, Ippolito E. Scoliosis and spine involvement in fibrous dysplasia of bone. Eur Spine J 2009; 18:196-202.
23. Meredith DS, Healey JH. Twenty-year follow-up of monostotic fibrous dysplasia of the second cervical vertebra: a case report and review of the literature. J Bone Joint Surg Am 2011; 93:e74.
24. Fitzpatrick KA, Taljanovic MS, Speer DP, Graham AR, Jacobson JA, Barnes GR, Hunter TB. Imaging findings of fibrous dysplasia with histopathologic and intraoperative correlation. Am J Roentgenol 2004; 182:1389-1398.
25. Candeliere GA, Glorieux FH, Prud'homme J, St-Arnaud R. Increased expression of the c-fos proto-oncogene in bone from patients with fibrous dysplasia. N Engl J Med 1995; 332:1546-1551.
26. Park SK, Lee IS, Choi JY, Cho KH, Suh KJ, Lee JW, Song JW. CTand MRI of fibrous dysplasia of the spine. Br J Radiol 2012; 85:996-1001.
27. Kaur H, Verma S, Jawanda MK, Sharma A. Aggressive osteoblastoma of the mandible. A diagnostic dilemma. Dent Res J 2012; 9:334-337.
28. Troop JK, Herring JA. Monostotic fibrous dysplasia of the lumbar spine: case report and review of the literature. J Pediatr Orthop 1988; 8: 599-601.
29. Siegel IM. Maintenance of ambulation in Duchenne muscular dystrophy. The role of the orthopedic surgeon. Clin Pediatr (Phila) 1980; 19:383-388.
30. Smith SE, Green NE, Cole RJ, Robison JD, Fenichel GM. Prolongation of ambulation in children with Duchenne muscular dystrophy by subcutaneous lower limb tenotomy. J Pediatr Orthop 1993; 13:336-340.